Atreca, Inc. 0C1.MU Stock
Atreca, Inc. Price Chart
Atreca, Inc. 0C1.MU Financial and Trading Overview
Atreca, Inc. stock price | 0.17 EUR |
Previous Close | 1.03 EUR |
Open | 1.07 EUR |
Bid | 1.06 EUR x N/A |
Ask | 1.09 EUR x N/A |
Day's Range | 1.07 - 1.07 EUR |
52 Week Range | 0.75 - 2.66 EUR |
Volume | 6.57K EUR |
Avg. Volume | 0 EUR |
Market Cap | 38.83M EUR |
Beta (5Y Monthly) | 1.075975 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.33 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0C1.MU Valuation Measures
Enterprise Value | 155.46M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.687219 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -1.696 |
Trading Information
Atreca, Inc. Stock Price History
Beta (5Y Monthly) | 1.075975 |
52-Week Change | -36.80% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2.66 EUR |
52 Week Low | 0.75 EUR |
50-Day Moving Average | 0.96 EUR |
200-Day Moving Average | 1.29 EUR |
0C1.MU Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 32.44M |
Float | 25.48M |
Short Ratio | N/A |
% Held by Insiders | 3.42% |
% Held by Institutions | 45.32% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:6 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -34.84% |
Return on Equity (ttm) | -93.87% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -91659000 EUR |
Net Income Avi to Common (ttm) | -93291000 EUR |
Diluted EPS (ttm) | -2.2 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 56.39M EUR |
Total Cash Per Share (mrq) | 1.44 EUR |
Total Debt (mrq) | 63.05M EUR |
Total Debt/Equity (mrq) | 103.42 EUR |
Current Ratio (mrq) | 4.24 |
Book Value Per Share (mrq) | 1.557 |
Cash Flow Statement
Operating Cash Flow (ttm) | -69614000 EUR |
Levered Free Cash Flow (ttm) | -36092000 EUR |
Profile of Atreca, Inc.
Country | Germany |
State | CA |
City | South San Francisco |
Address | 835 Industrial Road |
ZIP | 94070 |
Phone | 650 595 2595 |
Website | https://www.atreca.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 90 |
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria. Its products in pre-clinical stage include APN-497444, an antibody drug conjugate (ADC) against a novel tumor glycan target; and APN-346958, a CD3 bispecific T-cell engager against an RNA-binding protein target. It has a collaboration and license agreement with Xencor, Inc. for research, development, and commercialization of novel CD3 bispecific antibodies in oncology; licensing agreement with the Bill & Melinda Gates Medical Research Institute for the development and commercialization of MAM01/ATRC-501 for the prevention of malaria. The company was incorporated in 2010 and is based in San Carlos, California.
Q&A For Atreca, Inc. Stock
What is a current 0C1.MU stock price?
Atreca, Inc. 0C1.MU stock price today per share is 0.17 EUR.
How to purchase Atreca, Inc. stock?
You can buy 0C1.MU shares on the Munich exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Atreca, Inc.?
The stock symbol or ticker of Atreca, Inc. is 0C1.MU.
Which industry does the Atreca, Inc. company belong to?
The Atreca, Inc. industry is Biotechnology.
How many shares does Atreca, Inc. have in circulation?
The max supply of Atreca, Inc. shares is 38.41M.
What is Atreca, Inc. Price to Earnings Ratio (PE Ratio)?
Atreca, Inc. PE Ratio is now.
What was Atreca, Inc. earnings per share over the trailing 12 months (TTM)?
Atreca, Inc. EPS is -2.33 EUR over the trailing 12 months.
Which sector does the Atreca, Inc. company belong to?
The Atreca, Inc. sector is Healthcare.